Glenmark Pharma Rises Nearly 1% as US Arm Set to Launch Ropivacaine Hydrochloride Injection
Mumbai, October 23 (Udaipur Kiran) — Shares of Glenmark Pharmaceuticals gained nearly 1% in Thursday’s trading session after the company announced that its US-based subsidiary is preparing to launch Ropivacaine Hydrochloride Injection USP in multiple dosage strengths. The stock was trading at ₹1,873.20, up by ₹17.50 or 0.94%, from its previous close of ₹1,855.70 on … Read more
